U.S. Transportation Stock News

Regular readers will know that we love our dividends at Simply Wall St, which is why it's exciting to see Tetra Tech...

Urban Edge Properties (UE) recently paired stronger first quarter earnings with higher full year 2026 earnings guidance, giving investors fresh information on both current performance and management expectations for the rest of the year. See our latest analysis for Urban Edge Properties. The recent earnings beat and higher 2026 guidance come alongside a 13.14% year to date share price return and a 17.72% total shareholder return over the past year, suggesting momentum has built over time...

Tyson Foods, Inc.'s ( NYSE:TSN ) recent soft profit numbers didn't appear to worry shareholders, as the stock price...

From what we can see, insiders were net buyers in Vivani Medical, Inc.'s ( NASDAQ:VANI ) during the past 12 months...

Some investors rely on dividends for growing their wealth, and if you're one of those dividend sleuths, you might be...

Some investors rely on dividends for growing their wealth, and if you're one of those dividend sleuths, you might be...

Shareholders in Element Solutions Inc ( NYSE:ESI ) may be thrilled to learn that the analysts have just delivered a...

L.B. Foster Company's ( NASDAQ:FSTR ) recent soft profit numbers didn't appear to worry shareholders, as the stock...

Some AutoNation, Inc. ( NYSE:AN ) shareholders may be a little concerned to see that the Senior VP & Chief Accounting...

Some investors rely on dividends for growing their wealth, and if you're one of those dividend sleuths, you might be...

Last week, you might have seen that Chevron Corporation ( NYSE:CVX ) released its first-quarter result to the market...

Wintrust Financial Corporation ( NASDAQ:WTFC ) is about to trade ex-dividend in the next two days. The ex-dividend date...

A week ago, Ironwood Pharmaceuticals, Inc. ( NASDAQ:IRWD ) came out with a strong set of quarterly numbers that could...

Shareholders in Ionis Pharmaceuticals, Inc. ( NASDAQ:IONS ) may be thrilled to learn that the analysts have just...

Shareholders might have noticed that Nektar Therapeutics ( NASDAQ:NKTR ) filed its quarterly result this time last...

Unsurprisingly, Illumina, Inc.'s ( NASDAQ:ILMN ) stock price was strong on the back of its healthy earnings report. We...

A week ago, Callaway Golf Company ( NYSE:CALY ) came out with a strong set of quarterly numbers that could potentially...

Cencora, Inc. ( NYSE:COR ) is about to trade ex-dividend in the next three days. The ex-dividend date occurs one day...

Over the past year, insiders sold US$67k worth of Sypris Solutions, Inc. ( NASDAQ:SYPR ) stock at an average price of...

Some Bank of America Corporation ( NYSE:BAC ) shareholders may be a little concerned to see that insider Geoffrey...

In late April 2026, Marsh, a business of Marsh & McLennan Companies, announced a multi-year global partnership with Formula 1 as its first Official Risk Partner and Official Insurance Brokering Partner, alongside prominent trackside branding, curated race experiences, and a new content series on risk decision-making. Around the same time, Oliver Wyman, another Marsh & McLennan business, created senior AI-focused leadership roles to accelerate AI-enabled integration and transformation across...

uniQure (QURE) is in focus after first quarter results showed revenue of US$3.56 million and a net loss of US$53.54 million, alongside fresh regulatory progress for its Huntington’s disease gene therapy, AMT-130. See our latest analysis for uniQure. The stock has reacted strongly to the recent earnings update and regulatory progress on AMT-130, with a 1-month share price return of 79.84% and a 1-year total shareholder return of 110.34%, which may indicate building momentum rather than a...

Recent news around Kopin (KOPN) centers on its partnership with Fabric.AI, including a MicroLED Neural I/o chip program for AI data centers, new development funding, and fresh leadership for this joint effort. See our latest analysis for Kopin. The recent news flow appears to have coincided with sharp share price momentum, with a 30 day share price return of 103.38% and a 90 day share price return of 130.21%. This has contributed to a very strong 1 year total shareholder return of 249.03% and...

In early May 2026, PTC Therapeutics reported first-quarter revenue of US$272.55 million versus US$1.18 billion a year earlier, swinging from net income of US$866.56 million to a net loss of US$2.81 million while still beating analyst expectations on both revenue and earnings per share. The company also released positive 24-month interim data for Huntington’s disease therapy votoplam and raised its 2026 product revenue guidance, underscoring how a strong Sephience launch and advancing...